TELA Bio launches two larger OviTex LPR configurations for large abdominal hernia repair

TELA Bio, Inc.

New 15x20 cm and 15x25 cm ellipse sizes for ventral and incisional hernias.
Designed for robotic and laparoscopic ports; low profile facilitates minimally invasive placement.
In prior quarter, 40% of OviTex cases were robotic and 20% laparoscopic.
OviTex LPR initially commercialized in 2018; new sizes expand product portfolio.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.